Bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) for multidrug- or rifampin-resistant tuberculosis: a systematic review
ABSTRACT Objective: To evaluate the available evidence comparing the use of the bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) regimen for 6 months with that of standard-of-care regimens for patients with multidrug-resistant or rifampin-resistant tuberculosis (MDR/RR-TB). Methods: Th...
Saved in:
Main Authors: | Denise Rossato Silva, Flávia Fonseca Fernandes, Juliana Carvalho Ferreira, Wanderley Bernando, Margareth Maria Pretti Dalcolmo, Fernanda Dockhorn Costa Johansen, Fernanda Carvalho de Queiroz Mello |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Pneumologia e Tisiologia
2025-01-01
|
Series: | Jornal Brasileiro de Pneumologia |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132024000601500&lng=en&tlng=en |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Savings from the introduction of BPaL and BPaLM regimens at the country level
by: C. Auer, et al.
Published: (2024-07-01) -
Experience of piloting BPaLM/BPaL for DR-TB care at selected sites in Pakistan
by: M.A. Khan, et al.
Published: (2024-11-01) -
Development of sustained-release extemporaneous moxifloxacin loaded commercial soft hydrogel contact lenses
by: Duy Toan Pham, et al.
Published: (2025-02-01) -
Challenges faced during antitubercular therapy
by: B. K. Likhitha, et al.
Published: (2024-07-01) -
Development of a novelly selective HPLC-chemiluminescence method by targeting degradation intermediates of nitroimidazoles and its application in animal food products
by: Mengdie Cai, et al.
Published: (2025-01-01)